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Abstract
The current outbreak of COVID-19 has generated an unprecedented scientific response worldwide, with the generation of
vast amounts of publicly available epidemiological, biological and clinical data. Bioinformatics scientists have quickly
produced online methods to provide non-computational users with the opportunity of analyzing such data. In this review,
we report the results of this effort, by cataloguing the currently most popular web tools for COVID-19 research and analysis.
Our focus was driven on tools drawing data from the fields of epidemiology, genomics, interactomics and pharmacology, in
order to provide a meaningful depiction of the current state of the art of COVID-19 online resources.
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Introduction
SARS-CoV-2 emerged in late December 2019 in Wuhan, China,
as the seventh coronavirus shown to infect humans. Together
with SARS-CoV, the causative agent of the severe acute respira-
tory syndrome outbreak in 2003, and MERS-CoV, the pathogenic
coronavirus strain causing Middle East Respiratory Syndrome
in 2012, SARS-CoV-2 is the third betacoronavirus of zoonotic
origin to pose a serious threat to global health [1]. This novel
single-stranded positive RNA [(+) ssRNA] virus causes a mild
to severe respiratory disease named COVID-19 which can lead
to acute respiratory distress syndrome requiring intensive care
treatment, sepsis, septic shock and death in about 5.2% of diag-
nosed cases [2]. In less than 6 months, SARS-CoV-2 has spread
in 213 countries, counting more than 10 million tested-positive
cases, and more than half a million confirmed deaths [3].
SARS-CoV-2 has spread with astonishing ease across coun-
tries, and the initial lack of national or supra-national plans to
face health emergencies of such magnitude has had a diverse
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impact over different regions [4, 5]. A global responsewas quickly
developed in the form of collective data collection and analysis
efforts, generally aimed at understanding SARS-CoV-2 biology
and delivering therapeutic solutions in the form of clinical and
pharmacological protocols [6].
Strategies to defeat COVID-19 have been built on previously
developed methods for disease outbreak study, tracking and
containment [7], most notably those for influenza [8] and SARS
[9]. Specifically, classic epidemiological elements, such as case
incidence data and field surveys, have been integrated with
vast usage of next-generation sequencing technologies, such as
those provided by Oxford Nanopore and Illumina [10]. Different
methods for library preparation have been tested, based on
whole metatranscriptomic approaches, PCR amplification or
hybrid capture, designed to be able to extract SARS-CoV-2
sequences from both cultured media or pharyngeal swabs [11].
Sequencingmethods have been paired with classic phylogenetic
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Figure 1. Diagram of COVID-19 web tools described in this review. A few example
tools are indicated (for the full list, see Table 1).
divergence studies [12, 13]. Combining those distances with
different clustering techniques or phylogenetic trees and
network-based methods researchers can effectively track the
mutational evolution of SARS-CoV-2 genomes to trace COVID-
19 infection sources [14]. Genomic surveillance will also be
useful to identify novel mutations conferring a drug-resistant
or vaccine-resistant phenotype or altering virulence properties
[15].
Epidemiology and genomics have been supported in the fight
against SARS-CoV-2 by molecular biology and structural biology
to define the map of functional interactions between viral and
human proteins [16]. This interactomics approach collects data
on protein–protein interactions and also on drug-protein net-
works, whereas drugs can be targeted against viral proteins or
against specific host-virus interactions [17]. While SARS-CoV-
2 does not mutate at a high rate, with less than 25 predicted
mutations per year [18], constant mutation tracking is currently
being exercised, since any mutation could in theory influence
the development of specific antiviral therapies and vaccines
[19]. The further elucidation of the SARS-CoV-2/human protein
interaction network will greatly sustain the drug discovery pro-
cess [20], and most of the hypothesis-driven clinical trials on
FDA approved drugs have come from targets identified from
interactome maps, like ACE2 inhibitors [21].
The urgency of the COVID-19 crisis has ignited a previously
unseen global scientific response with unmatched speed and
multidisciplinary spirit, witnessing entire remodulation of pre-
viously existing laboratories and research programs. This has
fueled and reciprocally been fueled by the collection of a vast
amount of data that have been made freely accessible and
shared online [22]. In this scenario, data science and bioinfor-
matics play a prominent role in analyzing real-time information
to foster basic research and decipher viral biology, drug discovery
and disease management. A number of web tools for SARS-CoV-
2-related analysis have been specifically developed or readapted
to enable researchers to easily access the available data and
reanalyze it independently, thus sustaining the fast exchange
and the advance of COVID-19-related knowledge.
Here, we will provide an overview of the current state-of-the-
art of web resources specifically written or repurposed for SARS-
CoV-2 research. We will cover in particular platforms designed
to visualize and mine data from four major branches: epidemi-
ology, genomics, interactomics and pharmacology/clinical stud-
ies (Figure 1 and Table 1). We specifically selected, in our list,
efficient tools that are updated at least monthly, with clear
user guides and/or tutorials (available at the tools web sites). In
Table 2, a summary of all the features of the described tools is
provided.
Epidemiologic Data Collection and Analysis
Web Tools
The most established way to track a disease is to build epi-
demiologic maps collecting data about the number of confirmed
cases, deaths and recoveries on a spatial and temporal scale.
‘Dashboards’ have been the most common and popular tools in
this early phase, as user-friendly visualizers of geographic maps
highlighting cases and deaths country- and region- wise.
One of the first dashboards to be delivered to the public was
the COVID-19 Dashboard developed by the Center for Systems
Science and Engineering (CSSE) at Johns Hopkins University
(JHU) [23]. The JHU dashboard offers an interactive web-based
world map showing the real-time location and the number of
confirmed COVID-19 cases, deaths and recoveries for all affected
countries (Figure 2A). In addition to that, it offers a snapshot of
local and global incidence rates, number of tests, case fatality
ratios and rates of hospitalization that make it easy to com-
pare different responses across the countries. It also allows to
assess trends in specific countries and states, thus allowing us
to identify areas of exponential increase in case numbers. The
JHU dashboard is updated daily, and all the collected data are
shared through a GitHub repository (https://github.com/CSSEGI
SandData/COVID-19). A similar tool, the Demographics by State
COVID-19 Reporting (DSCovR) Dashboard, has been developed
by Columbia University. It is an interactive Shiny web app [24]
for the collection and visualization of COVID-19 cases in the
USA, displaying the age, sex and race distributions for con-
firmed cases, number of hospitalized cases and deaths for a
user-specified state. Trend comparisons across a maximum of
three states can be performed through intuitive web interfaces.
Alongside the JHU andDSCovR solutions, theWorld Health Orga-
nization (WHO) has also developed a public dashboard resource
to globally map COVID-19 cases and deaths and compare them
between geographic regions. The WHO Dashboard has a very
quick and intuitive interface, intended to be used by a vast public
beyond scientific audiences.
Beyond dashboards, other tools have been developed tomon-
itor COVID-19 epidemiology. One such tools, heavily focused on
real-time spreadsheet-like data sharing, is Worldometers.info,
a popular independent website originally intended to collect,
aggregate and perform statistical analyses on demographic data
from official sources. The Worldometers.info COVID-19 section
contains daily updated interactive tables and graphs summa-
rizing global and local reported cases, deaths and recoveries.
It contains informative tables about symptoms and reported
incubation time for SARS-CoV-2 infections, and statistics about
fatality rates grouped by age, sex and existing conditions or
comorbidities.
Unique functions are offered by COVID-19 Scenarios, an
interactive web application that simulates COVID-19 spreading
dynamics in a selected population-based upon different
epidemiological assumptions as well as the effect of measures
adopted to contain disease transmission [25]. COVID-19 Sce-
narios implements a basic age-stratified Susceptible-Exposed-
Infected-Recovered (SEIR) model [26] to build projections
that can be adjusted by modifying several parameters and
assumptions. For example, interventions like social distancing,
quarantine measures and case isolation policies can be
introduced in the model to evaluate their efficacy on mitigating
the severity of the outbreak on a temporal scale. Severity
of reported cases, age composition of populations and other
epidemiologic data can be added by users to refine their models.








































































Table 1. Web link, source and architecture of COVID-19 web tools described in this review, divided in four categories
Tool Link Main institution Nation Architecture
Epidemiology
JHU COVID-19 Dashboard coronavirus.jhu.edu/map.html Johns Hopkins University USA Python
DSCovR msph.shinyapps.io/dscovr_dashboard Columbia University USA Shiny/R
WHO Dashboard covid19.who.int WHO Worldwide JavaScript
Worldometers worldometers.info/coronavirus Worldometers.info USA JavaScript
COVID-19 Scenarios covid19-scenarios.org University of Basel Switzerland JavaScript
Harvard COVID-19 Simulator covid19sim.org Harvard Medical School USA R
CovidSIM covidsim.eu ExploSYS GmbH Germany JavaScript
COVID-19 Trajectory viewer apps.health-atlas.de/covid-19-grapher/ University of Leipzig Germany Shiny/R
COVID-19 exit strategies scienceversuscorona.shinyapps.io/covid-exit/ Science versus Corona initiative Worldwide Shiny/R
Greifswald COVID-19
Simulator
kaderali.org:3838/covidsim University of Greifswald Germany Shiny/R
COVID19-Tracker ubidi.shinyapps.io/covid19 Bellvitge Biomedical Research Institute Spain Shiny/R
Genomics
GISAID gisaid.org GISAID Worldwide CMS TYPO3
Nextstrain nextstrain.org/ncov/global University of Basel Switzerland Python
Covidex cacciabue.shinyapps.io/shiny2 University of Luján Argentina Shiny/R
Coronapp giorgilab.dyndns.org/coronapp University of Bologna Italy Shiny/R
COVID-19 Genotyping Tool covidgenotyper.app University of Toronto Canada Shiny/R
Pangolin pangolin.cog-uk.io Centre for Genomic Pathogen Surveillance UK Python
SARS-CoV-2 Alignment
Screen
macman123.shinyapps.io/ugi-scov2-alignment-screen University College London UK Shiny/R
CoV-GLUE cov-glue.cvr.gla.ac.uk University of Glasgow UK JavaScript
Coronavirus3D coronavirus3d.org University of California Riverside USA JavaScript
Interactomics
CoVex exbio.wzw.tum.de/covex/explorer Technical University of Munich Germany JavaScript
VirHostNet 2.0 virhostnet.prabi.fr University of Lyon France Cytoscape web




amp.pharm.mssm.edu/covid19 Icahn School of Medicine Mount Sinai USA JavaScript
canSAR corona.cansar.icr.ac.uk CRUK Cancer Therapeutics Unit UK JavaScript
CORDITE cordite.mathematik.uni-marburg.de University of Marburg Germany JavaScript
COVID-19 Disease Map covid19map.lcsb.uni.lu/minerva University of Luxemburg Luxemburg JavaScript
CoV-Hipathia hipathia.babelomics.org/covid19 Foundation for Progress and Health Spain Web Components
Chemical Checker sbnb.irbbarcelona.org/covid19 Institute for Research in Biomedicine Spain JavaScript
Clinical Trials clinicaltrials.gov/ct2/who_table WHO/NIH USA JavaScript

















Table 2. Features of COVID-19 web tools described in this review
Tool Tags Pros Cons
Epidemiology
JHU COVID-19 Dashboard Dashboard, interactive map, trend assessment,
worldwide
Frequently updated, quick assessment, worldwide
analysis
DSCovR Dashboard, interactive map, trend assessment Comparative region analysis, demographics
included
Slow to load, focused on USA
WHO Dashboard Dashboard, interactive map, worldwide Comparative region analysis, easy to use,
frequently updated, quick assessment, worldwide
analysis
Worldometers Spreadsheet, worldwide Easy to use, frequently updated, quick assessment,
worldwide analysis
COVID-19 Scenarios Interactive simulator, worldwide Demographics Included, high number of
parameters
Non-trivial to tailor the simulation
for specific regions
Harvard COVID-19 Simulator Interactive simulator Frequently updated Focused on USA
CovidSIM Interactive simulator High number of parameters Non-trivial to tailor the simulation
for specific regions
COVID-19 Trajectory viewer Interactive simulator Comparative region analysis
COVID-19 Exit Strategies Interactive simulator Comparison of several exit strategies Tunable parameters are few
Greifswald COVID-19 Simulator Interactive simulator Predict effect of social contact reduction Focused on specific countries and
German regions
COVID19-Tracker Case number visualizer and predictor Frequently updated Focused on Spain
Genomics
GISAID Data repository, worldwide Database fully downloadable, frequently updated,
precomputed multiple sequence alignment
Nextstrain Dashboard, nucleotide mutation analysis, phylogenesis,
worldwide
Frequently updated, simulation of mutation spread
over time, worldwide
Difficult to zoom into specific
regions of the interactive
phylogenetic tree
Covidex Phylogenetic categorization Allows user-provided data, intuitive tutorial Works exclusively with
user-provided Data
Coronapp Amino acid mutation analysis, nucleotide mutation
analysis, frequency of mutations over time
Allows user-provided data, nucleotide and protein
mutations, worldwide
Slow to load
COVID-19 Genotyping Tool Phylogenetic categorization via 2D clustering Allows user-provided data Analysis is very slow, maximum
number of sequences is only 10
Pangolin Phylogenetic categorization, lineage assigner Allows user-provided data, intuitive assignment of
lineage
Analysis is slow
SARS-CoV-2 Alignment Screen Nucleotide mutation analysis Mutation analysis can be focused on specific
genomic regions or genes
Not frequently updated
CoV-GLUE Amino acid mutation analysis, nucleotide mutation
analysis, spreadsheet
Mutation analysis can be focused on specific
genomic regions or genes, mutations categorized
as replacements/insertions/deletions
Coronavirus3D Amino acid mutation analysis, 3D structure Allows to project mutations on viral protein
structures from PDB, frequently updated
Continued











Tool Tags Pros Cons
Interactomics
CoVex Interactome visualizer Allows to identify known drugs for selected target
proteins
VirHostNet 2.0 Interactome visualizer Prediction of novel interactions on user-provided
protein sequences
Analysis is slow
P-HIPSTer Interaction list Prediction of novel interactions using sequence-
and structure-based machine learning
Not focused on SARS-CoV-2
Pharmacology
COVID-19 Gene/Drug Set Library Curated lists of genes and drugs Lists can be searched, new sets can be proposed No link with external databases
canSAR Database of clinical trials, drugs and druggable targets Intuitive visualization of druggable interactome,
drug prediction
CORDITE Database of clinical trials, drugs and druggable targets Quick search Not frequently updated
COVID-19 Disease Map Database of drugs and pathways Search for relevant interactions between viral
proteins and human pathways
Interactome Labels are hard to
read, Not frequently updated, no
examples provided, not focused
on SARS-CoV-2
CoV-Hipathia Analysis of druggable pathways affected by gene
expression changes
Allows user-provided data Analysis is slow
Chemical Checker Database of drugs Drugs ranked by evidence quality and quantity,
frequently updated
Clinical Trials Database of clinical trials Frequently updated, fully comprehensive Not categorized by drugs
Downloaded from https://academic.oup.com/bib/article/22/2/690/5923945 by guest on 02 July 2021
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Figure 2. Screenshots of selected COVID-19 webtools described in this manuscript: the epidemiological dashboard from Johns Hopkins University (A), the time-wise
phylogenetic tree representation from NextStrain (B) and the human/SARS-CoV-2 interactome visualized by Covex (C).
level were due mainly to avoid overloading of local Intensive
Care Units (ICUs), COVID-19 Scenarios is a powerful tool to make
projections on SARS-CoV-2 transmission and severity at the
country level, also testing how different measures may mitigate
risks. Demographic data can be monitored over timespans,
predicting the periodicity of infections due to seasonal changes
across countries. This is a very useful function since preventive
social distancing and lockdown measures have a significant
impact on the quality of life and economic stability of a country.
All projections made through COVID-19 Scenarios can be
downloaded in .json or .tsv format. Online graphs can be easily
printed in .pdf through the web interface and shared through
weblinks, while the app source code has been made available
by developers on GitHub. A similar concept can be found in the
Harvard COVID-19 Simulator, an interactive Shiny web tool to
inform COVID-19 intervention policy decisions in the USA, and
CovidSIM, which applies a SEIR simulation model to estimate
the potential health impact of the COVID-19 pandemic on a
hypothetical European country [27]. COVID-19 trajectory viewer































































696 Mercatelli et al.
trajectories in the future [28]. The commonmeaning of trajectory
tools is to evaluate how different countries are responding to
the disease spreading in order to ‘flatten the curve’ i.e. to keep
infection rates manageable to help local public health services.
Predicting the effects of different strategies to respond to COVID-
19 is the focus of the COVID-19 Exit Strategies, which shows
the result of several overlapping approaches to lift lockdown in
terms of the number of cases, such as radical reopening, contact
tracing and intermittent reopening/lockdown.
Regional but high-quality tools are also available. For
example, a sophisticated web tool in German and English
language, called Greifswald COVID-19 simulator, can depict
epidemic curves across a selection of countries and German
regions, and predict the effects of social contact reduction
policies on case numbers andhospital capacity.Another regional
tool is COVID19-Tracker, a Shiny web app specifically designed
to collect and visualize epidemiologic data from Spain. Data on
COVID-19 diagnosed cases, ICU admissions and mortality are
automatically collected daily, and data trends can be visualized
for each of the different implemented analysis, including case
fatality rates, infection time (i.e. the time required from exposure
to COVID-19 diagnosis), the effects of intervention measures in
containing the outbreak, 3-days trend projections over newly
diagnosed cases and deaths and reproduction number (R0)
estimation. Analyses can be sorted by age and geographical
region (community) [29]. COVID19-Tracker Graphical User
Interface supports three languages: Spanish-Castilian, Catalan
and English.
Genomic Analysis Web Tools
The 29 903 nucleotides genomic sequence of SARS-CoV-2 was
shared on 5 January 2020 through GenBank (MN908947.3/-
NC_045512.2). It was annotated based on sequence similarity
to other coronaviruses [30]. This led researchers all around the
world performing sequence analysis to compare the originally
isolated virus with local cases, in search for mutations that
may trace back cases, both spatially and temporally, to further
explain potential differences in transmission and overall case
fatality rates reported across countries [18]. Like many other
RNA viruses, SARS-CoV-2 naturally accumulates mutations.
While most changes have limited to no effects, some mutations
may affect viral biology; for example, the Spike protein D614G
mutation has been associated with a higher case/fatality rate
[31]. Detecting and tracking the emergence of those mutations
defining viral clades or subtypes is essential to ameliorate our
knowledge on the viral biology, epidemiology, evolution and
pathogenesis. The emergence of subtypes, in fact, may alter the
interactions between viral particles and host, thus affecting the
development of effective antiviral drugs and therapies. Genomic
analyses have also had a critical role in the design of ad hoc
molecular diagnostics to ameliorate the reliability and ease
of use of kit and tests for viral detection, supporting decision
making in disease management, especially in the case of host
genetic heterogeneity [10].
SARS-CoV-2 sequence data have been publicly available
through different sources. Most of the analyses that have been
made worldwide rely on sequences shared through the GISAID
Initiative database (Global Initiative on Sharing All Influenza
Data) [8]. The GISAID platform was launched in 2008 with the
aim of helping researchers focused on virology/epidemiology by
the sharing of data collected between the WHO Collaborating
Centers and National Influenza Centers. Available data on the
GISAID portal include genetic sequence and related clinical
and epidemiological data, as well as geographical information
linked to the submitting laboratories. This platform greatly
supported researchers in understanding SARS-CoV-2 origin,
evolution and spread since the first evidence that a novel
virus was circulating in China. Access to data is granted upon
registration, and it includes all submitted sequences in FASTA
format, as well as precomputed multiple sequence alignments
and comprehensive sample description tables (including date
and region of collection and clinical parameters of the host).
The exceptional sharing of genomic data during the COVID-
19 pandemic, with more than 50 000 SARS-CoV-2 genomes pub-
licly available on the GISAID repository, has fueled the devel-
opment of close to real-time data visualization and analysis
tools. One of the first and most known platforms specifically
developed for real-time tracking of pathogen evolution is the
Nextstrain project [32]. Nextstrain combines a daily updated
database of viral genomes, a bioinformatics pipeline for phylody-
namics analysis, and an interactive visualization platform into
a single open web application (Figure 2B), to assist virologists
and epidemiologists to share and analyze data. The architecture
of Nextstrain is well designed and responds to the need for a
continual surveillance to prevent uncontrolled outbreaks. The
existence of Nextstrain allowed researchers from across the
world respond promptly to the emergence of COVID-19 and
to track the population movements associated with outbreaks
via a combination of time, geography and mutation data [33].
Many other web tools rely on Nextstrain architecture to visualize
data. Nextstrain source code (mainly JavaScript and Python) is
shared on GitHub. It is worthwhile to highlight that the GISAID
and Nextstrain teams are closely collaborating: upon connection
via the GISAID website, users can browse phylogenetic trees
and graphs produced by the Nextstrain Next-hCoV-19 interac-
tive web interface, which provides updated phylogenetic and
mutational analysis of GISAID-shared data.
Viral sequence subtype classification can be computationally
demanding, especially for longer sequences. Most of the
web tools for phylogenomic analyses offer an easy, fast and
accurate classification of viral genomes taking advantage of
different methods to maximize analysis performances [34].
Almost all of the web apps share a similar architecture and
support phylodynamic analysis on preload sequence data or let
users to submit their own sequences in FASTA format (multi-
FASTA is frequently supported), and also offer visualization
functions for the results. Covidex is a web application for
phylogenetic analysis of viral genomes based on machine
learning, with freely available code at https://sourceforge.net/
projects/covidex/.Users can train their ownmodels by uploading
data on the Covidex model generator which implements a
random forest classifier over a k-mer database, or run their
analyses using Covidex-preloaded models [35]. Coronapp is
an interactive Shiny based web-application for fast detection
and monitoring of SARS-CoV-2 mutations worldwide [36].
The coronapp engine generates within seconds a mutational
map using GISAID data or user-submitted sequences, then
visualizes the results producing bar plot graphs summarizing
most frequent mutations detected and showing the abundance
and frequency of each individual mutation in an interactive
dot plot. Each analysis can be visualized on a global scale or
country-wise, and the results are made available for download
in tabular format. The source code of coronapp is available
on GitHub. Similar functions are also offered by the COVID-19
Genotyping Tool (CGT), where sequence similarity is visualized
in interactive maps by Uniform Manifold Approximation and
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networks [39]. Results can be visualized by filtering for sample-
associated metadata, which includes information on where and
when the samples were taken, and, if available, also the travel
history of the individual whose sample was collected from. CGT
allows users to upload up to 10 complete COVID-19 sequences
in FASTA format to be processed with preloaded GISAID data,
but processing may take several minutes before visualization.
Pangolin (Phylogenetic Assignment of Named Global Out-
break LINeages) is currently the leading web resource tomonitor
the current status of worldwide SARS-CoV-2 mutations, allow-
ing also the annotation and phylogenetic localization of user-
provided sequences. One of the two currently most popular
SARS-CoV-2 lineage nomenclatures was defined by the Pangolin
analysis [40], while another one has been proposed by GISAID.
The main viral clades identified by both systems are the same,
and there exists a 1:1 correspondence between the two nomen-
clatures [18]. Visualization of the results is made possible by
the connection with Microreact, a web application to display
datasets through trees, geographical, temporal and associated
metadata views [41]. A snapshot of the current distribution of
genomic diversity can also be obtained through SARS-CoV-2
Alignment Screen, an R Shiny interactive web resource focused
on visualizing specific viral genes [42]. Pangolin’s whole source
code is available at https://github.com/hCoV-2019/pangolin.
Amino acid sequence variations detection is one of the
main features of CoV-GLUE, another web application offering
the possibility for users to browse GISAID genomic data
comparative analysis by filtering the results using country,
collection date and phylogenetic lineage as criteria. Changes
within the virus genome are organized in three separate tabs
(replacements, insertions and deletions), that can be further
filtered by user-selected criteria including viral protein, codon
position, sequence distance, the number of sequences in which
the replacement is found and the type of occurring amino acid
substitutions. CoV-GLUE provides phylogenetic classification
and mutation analysis, with an interactive phylogenetic tree
showing the placement of the submitted sequences within
the global reference evolutionary model. The final analysis
also includes a diagnostic primer/probe design report to detect
polymorphismswhichmay reduce the effectiveness of detection
assays that can be very useful when locally detected sequences
are analyzed and monitored [43].
Changes in SARS-CoV-2 genomic sequence may affect viral
proteins 3D structures and functions. Unique features are
offered by Coronavirus3D server [44], a web-based viewer for 3D
visualization and analysis of the SARS-CoV-2 protein structures
from the Protein Data Bank (PDB) integrating information
on SARS-CoV-2 mutational patterns retrieved from China
National Center for Bioinformation. Since changes in SARS-CoV-
2 genomic sequence may affect viral proteins 3D structures and
functions, this tool may be particularly interesting to identify
and model mutations causing peculiar phenotypes, like more
transmissible or aggressive strains, or to test the hypothesis
for insurgence of viral subtypes showing altered recognition
patterns or altered protein functions. Interactive visualization of
the selected structure ormodels with coloring options according
to the mutation frequency is provided.
Interactomics Web Tools
One of the most urgent challenges of the COVID-19 emergency
is the identification of effective antiviral drugs and therapies
to limit transmission and manage the most severe cases.
Understanding the molecular mechanisms driving viral-
host interactions is crucial to identify potential target and
drug candidates, or to foster vaccine and drug development.
The identification of Protein–Protein Interactions (PPIs), PPI
networks or protein-drug interaction networks greatly facili-
tates the discovery of potential targets and drug candidates,
particularly following in silico drug repurposing approaches
[45], sustained by characterization of SARS-CoV-2 protein
structures and complexes, and by antiviral drugs or inhibitors,
measured experimentally or inferred by molecular docking
analysis [46].
PPI network analysis approaches have been adopted at the
early onset of COVID-19 pandemic [20] and now can be easily
performed by using several different web tools. For example,
CoVex (CoronaVirus Explorer) is a systems medicine-oriented
web platform integrating known coronavirus PPIs and drug-
protein interactions into an interactive large-scale interactome
(Figure 2C). Users may search the human interactome for drug-
gable targets or repurposable drug candidates (or a combination
of the two) by querying the interactive map and obtaining tables
describing potential drugs. Each drug receives a score rating the
relevance of the selected drug to the target, together with infor-
mation about FDA approval, ongoing or closed clinical trials and
relevant literature information. Alternatively, users can upload a
list of targets as starting seeds to guide the analysis [47]. CoVex
source code is available upon request. A manual curation of
Coronaviridae/host PPI networks is at the base of the COVID-
19 updated version of VirHostNet 2.0, a Cytoscape-based web
library providing access to a complete resource of virus–virus
and virus–host PPIs and network visualization [48]. The sources
of VirHostNet 2.0 interaction database are manually curated
and derive primarily from the Krogan lab human/SARS-CoV-
2 experimental interactome [17]. Three main query modes are
available in VirHostNet: a simple query for protein/domain/path-
way/taxonomy/literature search, browsing the database by viral
family or species of interest, or by prediction and visualization
of virus-virus and virus-host PPIs from raw primary protein
sequences, submitted in FASTA format, which is particularly of
interest when investigating possible intra-host drug-resistant
viral quasispecies. The P-HIPSTer (Pathogen-Host Interactome
Prediction using STructurE similaRity) algorithm gathers infor-
mation from several viruses and drugs to infer potential PPIs
for the user-selected virus (SARS-CoV-2 is one of the options).
It exploits both sequence- and structure-based information to
infer interactions between pathogen and human proteins. The
P-HIPSTer database can be accessed through the web interface
by selecting a virus or a human protein of interest to obtain a
table containing known virus-host PPIs, also indicating which of
the results have PDB structures available [49].
Pharmacology Web Tools
Since the first cases of COVID-19 have been described, an
increasing number of papers and preprints have become
available reporting in silico and in vitro testing of potential drug
candidates, as well as clinical experiences of drug repurposing,
leading to a potentially harmful confusing landscape consider-
ing how media have overexposed several potential remedies.
An attempt to organize this rapidly evolving knowledge, to
make it more suitable for researchers, is the main purpose of
the COVID-19 Gene and Drug Set Library [50]. This site gathers
NGS and transcriptomic experiments to offer a collection of
differentially expressed genes in coronavirus-infected human































































698 Mercatelli et al.
research delivered through a web-based interface. Currently,
users can browse among 420 different gene sets (and a total
of 16 765 unique genes) and 120 drug sets (1397 unique drugs),
download the original datasets of interest and contribute to
expand the COVID-19 Gene and Drug Set Library by submitting
their own datasets. While supported by a large database, the
web interface is not providing links to external databases, which
could provide extra information on drugs (e.g. DrugBank [51]) or
genes (e.g. GeneCards [52]).
Datasets can be also analyzed for overlapping by automati-
cally plotting Venn diagrams,while tables and ranking functions
are also available. A similar effort has been made in developing
canSAR, an integrated knowledge database that collects and
organizes multidisciplinary data, comprising biological, chem-
ical, pharmacological and clinical annotation data. Machine
learning approaches such as polynomial regression and neural
networks are then applied to provide drug discovery predictions
[53]. Users can enter proteins/diseases or even structures of
interest in the query form, which returns several results that
can be further refined by setting the advanced search options.
CORDITE (CORona Drug InTERactions database) is another
database collecting curated data on potential druggable targets
coming from published articles and preprints considering both
original research articles, reviews and comments [54]. CORDITE
makes collected data accessible via a webserver and an open
API to programmatically access to the database. Users can
easily browse across interactions, targets, drugs, publications
and clinical trials, to carry out meta-analyses on potential drug
candidates for clinical trials or to identify effective treatments by
integrating the information coming from this curated database
into other software or apps. A similar attempt guides the COVID-
19 Disease Map, a collective effort bringing together clinical
researchers, life scientists, pathway curators, computational
biologists and data scientists to build a knowledge repository
of molecular mechanisms of COVID-19 summarizing host-
pathogen interactions specific to SARS-CoV-2. The COVID-19
DiseaseMap offers a platform for visual exploration ofmolecular
processes involved in SARS-CoV-2 entry, replication and host-
pathogen interactions, as well as immune response and host
repair mechanisms, suggesting potential targets of intervention,
together with possible interacting drugs [55]. The same effort
brought to the development of CoV-Hipathia (COVID-19 Pathway
Interpretation and Analysis), a simple method to investigate
rewiring of human cell signaling pathways following SARS-CoV-
2 infection. The CoV-Hipathia web tool shows which druggable
pathways are relevant for the viral cycle and are affected in
user-provided gene expression data [56].
More clinically oriented tools also exist. One is Chemical
Checker, a daily updated database collecting a literature-curated
list of bioactive chemical compounds potentially effective in
treating COVID-19. Chemicals are catalogued via evidence
levels: text mining search, computational, preclinical and
clinical. Furthermore, Chemical Checker categorizes compounds
via their biochemical/biological mode of action, cataloguing
them as immunomodulators, protease inhibitors, polymerase
inhibitors, virus entry blockers and so on. A full list of currently
ongoing or completed COVID-19 clinical trials (∼1800) has been
compiled by the WHO and can be searched via the ad hoc
extension of the US National Institute of Health’s ClinicalTria
ls.gov website. This allows the sorting of clinical studies by
drug or procedure name, recruitment status, date, among other
criteria.
Discussion
Despite early and constant warnings about the risk of bat-
derived zoonosis viruses after the 2003 SARS epidemic [57] SARS-
CoV-2 has found the world health systems unprepared to deal
with it. SARS-CoV-2 rapidly evolved into a global health and
economic challenge no country was prepared to face, from a
Public Health Emergency of International Concern on 30 January
2020 to a global pandemic on 11 March 2020 by the WHO.
As the emergence of a novel coronavirus arose quickly, data
scientists and bioinformaticians have promptly responded to the
COVID-19 pandemic by developing SARS-CoV-2 specific tools to
support research and advancing knowledge on biology, pathol-
ogy, epidemiology and treatment of COVID-19, building on and
taking inspiration from preexisting platforms like Nextstrain
and the GISAID Initiative.
In this review, we bear testimony of the current effort per-
formed by bioinformatics in fighting SARS-CoV-2 in the form
of online tools. We were surprised by the quality, speed of
development and abundance of the current resources, showing
a vital field pervaded by a spirit of sharing of data, code and
ideas. Virtually all web tools currently available freely provide
the underlying data, in the form of genomic sequences, epidemi-
ological tables, interaction maps and clinical information and
the majority of the tools also provide the underlying code for
data visualization. We noticed also a commendable effort by all
developers to provide tools that are easy to use also for non-
computational users, allowing a vast audience to quickly analyze
COVID-19 data. This is having and will have indubitable positive
effects in the current research effort against the pandemic,
as it allows to access information that can have immediate
political and social applications (based on epidemiology data
and models) and on clinical decisions (based on the integrated
mutational/pharmacological/Interactomics data available).
A shared limitation of all tools described here is the lack
of full data coverage on the COVID-19 pandemic: except for a
few countries, testing is not performed on the totality of the
population and genomic data are even scarcer, especially in
less developed countries [58]. While some web tools are more
developed and providing a higher quantity of information than
others, we believe that each resource presented here (Table 1) is
uniquely useful in a specific task (summarized in Table 2) and
we will leave to the readers the decision of which tool is ‘best’
for their particular scientific enquiry.
It is notable that, while the majority of currently existing
web tools to analyze SARS-CoV-2 utilize custom JavaScript
frameworks, roughly a third of them are written using R/Shiny
solutions [24]. Apart from the technical advantages of the Shiny
server (speed, ease of deployment, stability, integration with
JavaScript), this is probably the result of the current worldwide
popularity of the R language. R provides tools to perform
biological sequence analysis, through the Bioconductor initiative
[59], excellent data visualizationmethods andhigh-performance
machine learning algorithms. Beyond our analysis, several non-
web R packages have been developed in the first months after
COVID-19 outbreak beyond webtools, such as the R packages
(deposited on the CRAN repository [60]) coronavirus, COVID19,
covid19italy and covid19.analytics, which provide daily updates
on COVID-19 case numbers from several official sources. An
exhaustive list drawn for COVID-19 collected more than a 100 R
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While many of these resources are prototypes and roughly 50%
are not frequently updated, their quick deployment stands as
proof of the very vital status of the R bioinformatics community.
Furthermore, the web development effort of the bioinformat-
ics community against COVID-19 is not limited to the genera-
tion of data analysis and visualization tools. For example, one
popular resource that goes beyond the scope of our manuscript
is PlatCOVID (https://platcovid.com/), an online website/com-
munity where scientists share literature and information about
COVID-19. The PlatCOVID web portal collects, classifies, clusters
and ranks all literature related to SARS-CoV-2, allowing users to
actively comment on each new publication.
While peer-reviewed publications and clinical trials must
remain the prime source for clinical decisions and research facts,
online tools are speeding up the sharing of COVID-19 real-time
information, thus allowing for quick situational assessments
and a faster clinical and scientific response to e.g. mutational
events. In this historical conjuncture, the combination of the
internet, large data collection, worldwide bioinformatical anal-
ysis efforts and machine learning algorithms are improving our
ability to manage the current COVID-19 pandemic. The bene-
ficial effects of web tools will limit the economic and clinical
burden in every country and will constitute a technological basis
to fight more COVID-19 outbreaks and future epidemics.
Key Points
• COVID-19 has stimulated the fast creation of dedi-
cated web tools.
• COVID-19 web tools are mostly providing the means
to analyze data from epidemiology, genomics, interac-
tomics and pharmacology.
• Weprovide here a selection of popular and useful tools
to analyze publicly available (and, in some cases, user-
provided) COVID-19 data.
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